- Report
- February 2025
- 221 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- March 2025
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 190 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 181 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 197 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 200 Pages
Global
From €2364EUR$2,490USD£1,994GBP
- Report
- August 2024
- 200 Pages
Global
From €2174EUR$2,290USD£1,834GBP
- Report
- November 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 192 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 196 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 94 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- April 2024
- 138 Pages
Global
From €2847EUR$2,999USD£2,402GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more